Merck KGaA
MKKGY
$32.38
$0.050.16%
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 6.20B | 5.89B | 6.11B | 6.22B | 5.96B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 6.20B | 5.89B | 6.11B | 6.22B | 5.96B |
| Cost of Revenue | 2.59B | 2.37B | 2.57B | 2.46B | 2.53B |
| Gross Profit | 3.61B | 3.52B | 3.54B | 3.76B | 3.44B |
| SG&A Expenses | 1.79B | 1.74B | 1.79B | 1.71B | 1.68B |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 187.21M | -52.10M | -58.20M | -149.65M | 137.33M |
| Total Operating Expenses | 5.34B | 4.82B | 5.03B | 4.79B | 4.95B |
| Operating Income | 859.59M | 1.07B | 1.08B | 1.43B | 1.01B |
| Income Before Tax | 730.59M | 996.91M | 466.80M | 1.31B | 940.86M |
| Income Tax Expenses | 166.67M | 229.52M | 89.64M | 263.05M | 197.48M |
| Earnings from Continuing Operations | 563.93M | 767.39M | 377.17M | 1.05B | 743.38M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -4.57M | -10.67M | -5.82M | 4.68M | -3.40M |
| Net Income | 559.36M | 756.72M | 371.35M | 1.05B | 739.97M |
| EBIT | 859.59M | 1.07B | 1.08B | 1.43B | 1.01B |
| EBITDA | 1.43B | 1.63B | 1.52B | 1.96B | 1.50B |
| EPS Basic | 1.29 | 1.74 | 0.85 | 2.42 | 1.70 |
| Normalized Basic EPS | 1.04 | 1.41 | 1.83 | 1.89 | 1.35 |
| EPS Diluted | 1.29 | 1.74 | 0.85 | 2.42 | 1.70 |
| Normalized Diluted EPS | 1.04 | 1.41 | 1.83 | 1.89 | 1.35 |
| Average Basic Shares Outstanding | 433.63M | 433.82M | 434.80M | 435.75M | 434.67M |
| Average Diluted Shares Outstanding | 433.63M | 433.82M | 434.80M | 435.75M | 434.67M |
| Dividend Per Share | -- | -- | 2.56 | -- | -- |
| Payout Ratio | 208.98% | 2.06% | 0.00% | -- | 152.30% |